Andere talen Lucid Diagnostics Inc.

Aandelen

LUCD

US54948X1090

Vertraagde tijd Nasdaq Andere beurzen 17:51:33 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,675 ^USD	+0,73%		-15,25%	-52,13%

27/03	LUCID DIAGNOSTICS INC. : Cantor Fitzgerald handhaaft koopadvies	ZM
26/03	Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lucid Diagnostics : Corporate Presentation - March 2024	03/04
PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results	27/03
Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Lucid Diagnostics Inc. Announces Positive Data from the First Prospective Clinical Validation Study of Esoguard Esophageal Precancer Testing in A Screening Population	21/03
Lucid Diagnostics Inc. announced that it has received $18.16 million in funding	13/03
Lucid Diagnostics Provides Update Regarding World Trade Center Health Program	19/02
Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors	09/02
Lucid Diagnostics Inc. Executes Contract to Provide Esoguard® Esophageal Precancer Testing as A Covered Benefit for 9/11 Responders and Survivors	08/02
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	12/12
Lucid Diagnostics Inc. and Pavmed Inc. Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	12/12
Lucid Diagnostics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Lucid Diagnostics Inc. Appoints Shaun M. O?Neil as President	13/11
PAVmed to Hold a Business Update Conference Call and Webcast on November 15, 2023	01/11
Lucid Diagnostics Inc. announced that it has received $5 million in funding	01/11
Lucid Diagnostics : Private Placement - Form 8-K	18-10-23
Lucid Diagnostics Inc. announced that it expects to receive $5 million in funding	18-10-23
Lucid Diagnostics Inc. announced that it has received $5 million in funding	18-10-23
Lucid Diagnostics Inc. announced that it expects to receive $5 million in funding	17-10-23
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference	21-09-23
Lucid Diagnostics Inc. Releases Positive Data from First Prospective Clinical Utility Study of Esoguard®? Esophageal Precancer Detection	07-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lucid Diagnostics Inc.

Aandelen

LUCD

US54948X1090

Andere talen

Filters